Cargando…

Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas

BACKGROUND: Heterogeneity and low incidence comprise the biggest challenge in sarcoma diagnosis and treatment. Chemotherapy, although efficient for some sarcoma subtypes, generally results in poor clinical responses and is mostly recommended for advanced disease. Specific genomic aberrations have be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brodin, Bertha A., Wennerberg, Krister, Lidbrink, Elisabet, Brosjö, Otte, Potdar, Swapnil, Wilson, Jennifer N., Ma, Limin, Moens, Lotte N., Hesla, Asle, Porovic, Edvin, Bernhardsson, Edvin, Papakonstantinou, Antroula, Bauer, Henrik, Tsagkozis, Panagiotis, von Sivers, Karin, Wejde, Johan, Östling, Päivi, Kallioniemi, Olli, Stragliotto, Christina Linder
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462037/ https://www.ncbi.nlm.nih.gov/pubmed/30745580 http://dx.doi.org/10.1038/s41416-018-0359-4

Ejemplares similares

Current Status of Management and Outcome for Patients with Ewing Sarcoma
por: Hesla, Asle Charles, et al.
Publicado: (2021)

Evaluation of PD-L1 Expression in Undifferentiated Pleomorphic Sarcomas, Liposarcomas and Chondrosarcomas
por: Zhang, Yifan, et al.
Publicado: (2022)

Subsequent primary neoplasms among bone sarcoma survivors; increased risks remain after 30 years of follow-up and in the latest treatment era, a nationwide population-based study
por: Hesla, Asle Charles, et al.
Publicado: (2020)

Transcriptome profiling of Ewing sarcomas – treatment resistance pathways and IGF‐dependency
por: Chen, Yi, et al.
Publicado: (2020)

Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose–response data
por: Mpindi, John-Patrick, et al.
Publicado: (2015)

Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data
por: Potdar, Swapnil, et al.
Publicado: (2023)

Breeze: an integrated quality control and data analysis application for high-throughput drug screening
por: Potdar, Swapnil, et al.
Publicado: (2020)

Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years
por: Hesla, Asle Charles, et al.
Publicado: (2018)

Sclerotherapy with polidocanol for treatment of aneurysmal bone cysts: Good results in 37 of 38 consecutive patients
por: Brosjö, Otte, et al.
Publicado: (2013)

An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma
por: Tsagozis, Panagiotis, et al.
Publicado: (2019)

Identification of structural features in chemicals associated with cancer drug response: a systematic data-driven analysis
por: Khan, Suleiman A., et al.
Publicado: (2014)

The Tumor Microenvironment of Pediatric Sarcoma: Mesenchymal Mechanisms Regulating Cell Migration and Metastasis
por: Ehnman, Monika, et al.
Publicado: (2019)

TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma
por: Zhang, Yifan, et al.
Publicado: (2021)

Preoperative radiotherapy of soft-tissue sarcomas: surgical and radiologic parameters associated with local control and survival
por: Tsagozis, Panagiotis, et al.
Publicado: (2018)

CD11c-CD8 Spatial Cross Presentation: A Novel Approach to Link Immune Surveillance and Patient Survival in Soft Tissue Sarcoma
por: Su, Yanhong, et al.
Publicado: (2021)

Intra-Articular Synovial Sarcomas: Incidence and Differentiating Features from Localized Pigmented Villonodular Synovitis
por: Nordemar, D., et al.
Publicado: (2015)

Noncoding RNA in drug resistant sarcoma
por: Li, Xiaoyang, et al.
Publicado: (2017)

Primary Reticulum-Cell Sarcoma of Bone in Western India
por: Potdar, G. G.
Publicado: (1970)

The usefulness of SARC-F
por: Piotrowicz, Karolina, et al.
Publicado: (2021)

Surgical Treatment of Bone Sarcoma
por: Bläsius, Felix, et al.
Publicado: (2022)

Workshop report on the 2(nd) Joint ENCCA/EuroSARC European bone sarcoma network meeting: integration of clinical trials with tumour biology
por: Anninga, Jakob K, et al.
Publicado: (2014)

Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)
por: Kim, AeRang, et al.
Publicado: (2020)

A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results
por: Attia, Steven, et al.
Publicado: (2022)

A retrospective study of SBRT of metastases in patients with primary sarcoma
por: Stragliotto, Christina Linder, et al.
Publicado: (2012)

A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening
por: Gupta, Abhishekh, et al.
Publicado: (2020)

Drug repositioning in sarcomas and other rare tumors
por: Lee, Alex T.J., et al.
Publicado: (2016)

Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study
por: Hall, Kirsten Sundby, et al.
Publicado: (2020)

Detection of EWS/FLI-1 by Immunostaining. An Adjunctive Tool in Diagnosis of Ewing's Sarcoma and Primitive Neuroectodermal Tumour on Cytological Samples and Paraffin-Embedded Archival Material
por: Nilsson, Gunnar, et al.
Publicado: (1999)

Comparison of Diagnostic Performance of SARC-F and Its Two Modified Versions (SARC-CalF and SARC-F+EBM) in Community-Dwelling Older Adults from Poland
por: Krzymińska-Siemaszko, Roma, et al.
Publicado: (2020)

Comparing SARC-CalF With SARC-F for Screening Sarcopenia in Adults With Type 2 Diabetes Mellitus
por: Xu, Zeru, et al.
Publicado: (2022)

Diagnostic performance of calf circumference, SARC-F, and SARC-CalF for possible sarcopenia screening in Indonesia
por: Kandinata, Stefanus G., et al.
Publicado: (2023)

Diagnostic performance of SARC-F and SARC-CalF in screening for sarcopenia in older adults in Northern Brazil
por: Barreto de Lima, Alex, et al.
Publicado: (2023)

Chemotherapeutic drugs for soft tissue sarcomas: a review
por: Tian, Zhichao, et al.
Publicado: (2023)

Comprehensive data-driven analysis of the impact of chemoinformatic structure on the genome-wide biological response profiles of cancer cells to 1159 drugs
por: Khan, Suleiman A, et al.
Publicado: (2012)

SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma
por: Chugh, Rashmi, et al.
Publicado: (2020)

Sarcopenia for predicting mortality among elderly nursing home residents: SARC-F versus SARC-CalF
por: Yang, Ming, et al.
Publicado: (2019)

Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model
por: Yadav, Bhagwan, et al.
Publicado: (2015)

Different patterns of clonal evolution among different sarcoma subtypes followed for up to 25 years
por: Hofvander, Jakob, et al.
Publicado: (2018)

The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24–25, 2015. Workshop Report
por: Kager, Leo, et al.
Publicado: (2016)

Understanding sarcoma drug resistance one cell at a time
por: Cherradi-Lamhamedi, Salah-Eddine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gf5f2nlk6lodalb6rg3gdd7j7l